Biohaven Pharmaceutical Holding Co Ltd.

CITADEL ADVISORS LLC

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

185,618

Value ($000)

28,060

Weight

0.0%

2019 Q4 - 2022 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	28,060	0.0%	185,618	9/30/2022
2022 Q2	8/15/2022	34,500	0.0%	236,775	6/30/2022
2022 Q1	5/16/2022	17,300	0.0%	145,912	3/31/2022
2021 Q4	2/14/2022	5,618	0.0%	40,766	12/31/2021
2021 Q3	11/15/2021	22,640	0.0%	162,981	9/30/2021
2021 Q2	8/16/2021	3,337	0.0%	34,374	6/30/2021
2021 Q1	5/21/2021	3,002	0.0%	43,922	3/31/2021
2020 Q4	2/16/2021	10,751	0.0%	125,439	12/31/2020
2020 Q3	11/16/2020	3,221	0.0%	49,547	9/30/2020
2020 Q2	8/14/2020	21,810	0.0%	298,319	6/30/2020
2020 Q1	5/15/2020	7,304	0.0%	214,625	3/31/2020
2019 Q4	2/14/2020	15,684	0.0%	288,097	12/31/2019